ior subcapsular cataracts, opportunistic ocular Background. Long-term visual outcome following infections, and steroid-induced raised intraocular renal transplantation is poorly documented in medical pressure [1][2][3]. The majority of the complications literature. The purpose of this study was to determine are attributed to immunosuppressive therapy. Howthe ocular morbidity in a group of renal transplant ever, medical complications directly related to renal patients receiving immunosuppressive therapy.
had complications of proliferative diabetic retinopathy; Subjects and methods one eye had diabetic maculopathy and one eye had a central retinal artery occlusion. Only five eyes had During the study period of 15 months between 1994 and irreversible visual loss resulting in visual acuities of 1996, patients who had undergone renal transplantation were less than 6/60.
identified from the renal outpatient register and referred for Conclusion. The incidence of sight-threatening com-ophthalmic examination. To ensure sufficient long-term plications in long-term survivors of renal transplanta-follow-up, only the patients who were at least 8 years posttion was low. The results indicate that long-term transplantation were included in the study. All except two patients were on a combination immunosuppressive regime prognosis for normal vision in patients who have of prednisolone with either cyclosporin or azathioprine or a undergone renal transplantation is good. Regular ophcombination of cyclosporin and azathioprine. Two patients thalmic examinations are recommended for early detecwere on cyclosporin alone.
Introduction
14.6 years after the renal transplantation. There were 43 males and 28 females, with ages ranging from 29 to 74 years.
The ocular complications following renal transplantaAll patients underwent a complete ocular examination tion have been well documented. These include poster-including best corrected Snellen visual acuity, assessment of the precorneal tear film, extent of conjunctival and corneal 
Results
or eyes previously operated for cataracts were also found relatively frequently in the study groups. 13-75% Table 1 summarizes the primary aetiology of the renal of the patients in the subgroups had clinically visible failure in the group of patients included in this study.
or previously operated cataracts. Total incidence of Post-transplantation immunosuppression regimes at subcapsular cataracts was 39%. In four eyes the visual the time of examination comprised: (i) dual therapy acuity was worse than 6/24 because of lens opacities. with prednisolone in combination with azathioprine in Nine eyes had undergone previous cataract extractions 49 patients; mean prednisolone dose of 7.9 mg/day with postoperative visual acuities of 6/9 or better. The (range 3-10 mg) and azathioprine dose of 115 mg/day incidence of cataracts was equal amongst patients on (range 50-200 mg); (ii) dual therapy with prednisolone dual and triple immunosuppression regimes. in combination with cyclosporin in 11 patients; mean Vascular events such as central/branch retinal-vein prednisolone dose of 9.5 mg (range 7-12.5 mg) and occlusions, central retinal artery occlusions and cyclosporin dose of 277 mg/day (range 175-400 mg);
anterior ischaemic optic neuropathies were relatively (iii) triple therapy with prednisolone in combination uncommon. Due to the small number of patients with with cyclosporin and azathioprine in nine patients. vascular events no correlation could be made between Mean prednisolone dose of 8 mg/day (range 4-10 mg), different immunosuppressive regimes and the incidence cyclosporin dose of 217 mg/day (range 100-250 mg) of vascular complications. Vascular complications and azathioprine dose of 83 mg/day (range 25-125 mg) related to hypertension or diabetes were associated (iv) single therapy with cyclosporin alone in two with 73% of the cases of irreversible visual loss. Four patients. Mean dose was 300 mg/day (range patients with central/branch retinal-vein occlusions; 200-400 mg). Due to the nature of the study design, one patient with complications of proliferative diabetic accurate estimation of the total dose of each drug retinopathy; one patient with a diabetic maculopathy received by patients during the post-transplantation and two patients with optic atrophy from non-arteritic period could not be calculated. Seven patients had anterior ischaemic optic neuropathy. Because of the acute rejection episodes requiring intravenous steroid small number of patients with irreversible visual loss treatment. On average, the duration of time on dialysis no conclusions could be drawn regarding the severity prior to transplantation was 40.5 months (range 3 of hypertension and the development of severe visual weeks to 10 years). Twenty-four patients were on loss. medication for hypertension, five patients requiring Ten patients were noted to have coincidental ocular more than one medication. abnormalities. One patient had anisometropic amblyFour main categories of ocular abnormalities were opia; one patient had corneal scarring; one patient had found in these patients. Corneal/conjunctival calcificadistichiasis/trichomegaly secondary to long-term cyclotion, lens changes, vascular events such as vein and sporin treatment; two patients had optic atrophy; two artery occlusions, and coincidental ocular abnormalitpatients showed disruption of the retinal pigment epiies such as retinal pigmentary changes, macula and/or thelium with a 'salt and pepper' appearance of the disc drusen and optic atrophy. One patient was noted fundus; one patient had retinoschisis and two patients to have raised intraocular pressure and commenced on had macula/optic nerve head drusen. treatment for glaucoma.
Visual outcome in terms of visual acuity in patients Table 2 summarizes the various ocular abnormalities.
following renal transplantation is shown in Table 3 . The results are presented in subgroups according to Visual acuity was greater than or equal to 6/9 in 75% the primary aetiology of the renal failure.
of the eyes. In 15 eyes (10%) the visual acuity was Corneal/conjunctival calcification was a common worse than 6/24. Four eyes had previous central/branch complication in all subgroups. No correlation could retinal-vein occlusions; four eyes had posterior subcapbe made between the duration of time on dialysis and sular lens opacities; three eyes had optic atrophy; one the development of corneal/conjunctival calcification. eye had complications of proliferative diabetic retinopathy; one eye had diabetic maculopathy; one eye had a central retinal artery occlusion; and one eye was Ocular complications in renal-transplant patients are reported to be associated with a significant morbidity.
*Congenital renal hypoplasia, Henoch-Schönlein purpura etc. The most common amongst these is lens opacities. The individual susceptibility and constitutional (genetic) factors as well as prolonged corticosteroid therapy incidence of posterior subcapsular cataract has varied from 25 to 50% in separate studies [1, 2, 5] . In the [7, 8] . Some reports indicate an increased tendency of lens changes to develop as the survival time after present series, the incidence was 39%. Most published data have documented a dose-dependent relationship transplantation increases [9] .
In the present study nine patients had undergone between oral corticosteroid treatment and cataracts [6 ] . However, the exact mechanism of posterior sub-cataract extraction with excellent results. Only three patients out of 19 with clinically visible lens opacities capsular cataract development may be dependent on Ocular morbidity following renal transplantation 2073 had visual deterioration to a level where cataract of pre-existing arteriosclerosis with calcification estabsurgery was recommended.
lished in the course of the patients original renal Elevated intraocular pressure is a potentially hazard-failure. The role of this non-diabetic vasculopathy on ous but fortunately rare complication of prolonged the retinal, choroidal, and optic nerve vasculature oral steroid therapy. This complication was observed remains to be determined so that effective therapy can in 1.4% of patients in the present study and the be initiated to ensure good visual outcome for all renal incidence is comparable to that observed in previous allograft recipients. series [1, 3] . Oral steroids are believed to cause a lower
In conclusion, we have found the incidence of sightincidence of raised intraocular pressure than topical threatening complications in this cohort of long-term steroids [3] . A rational explanation for this disparity survivors of renal transplantation to be low. Our may be the fact that oral steroids decrease both the results indicate that the long-term prognosis for normal formation of aqueous humour and facility of outflow vision in patients who have undergone renal transof aqueous in the trabecular meshwork, whilst topical plantation is good. However, regular ophthalmic steroids only decrease the facility of outflow of the examinations are recommended for early detection of aqueous humour in the trabecular meshwork [10] .
sight-threatening complications. The development of opportunistic infections such
